Cyclosporin A therapy for severe anterior scleritis. Five case reports of patients without associated systemic disease;Ciclosporin-A-therapie bei schweren anterioren skleritiden

Ophthalmologe

Volumn 97, Issue 12, 2000, Pages 863-869

  Hillenkamp, J ^a   Kersten, A ^a   Althaus, C ^a   Sundmacher, R ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cyclosporin; Immunosuppression; Scleritis

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IRIDOCYCLITIS; MALE; OPHTHALMOSCOPY; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FLUOCORTOLONE; HUMANS; MALE; RECURRENCE; SCLERITIS; TREATMENT OUTCOME;

EID: 0034480645     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470070010     Document Type: Article

References (13)

1. Skleritis und episkleritis
2. Cyclosporine A specifically inhibits function of nuclear proteins involved in T cell activation
3. Immunopathology of scleritis
4. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression
5. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis
6. Autoimmune disease in MRL/Mp-Ipr/Ipr mice is suppressed by anti-CD4 antibody
7. Complications of cyclosporin therapy
8. Cyclosporin: Immunology, pharmacology and therapeutic uses
9. Topical cyclosporine for treating necrotizing scleritis
10. An analysis of therapeutic decision for scleritis
11. Severity of scleritis and episcleritis
12. Cyclosporin therapy for severe scleritis